Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced ...
Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It ...
Organ transplantation typically requires the use of immunosuppressants with significant side effects to prevent rejection.
Beyond traditional monitoring of kidney transplant recipients, donor derived-cell free DNA may permit early identification of graft damage.
Eledon Pharmaceuticals Inc. (NASDAQ:ELDN) is one of the 10 Unstoppable Stocks That Could Double Your Money. Eledon ...
A first-in-human clinical trial at UPMC shows it is feasible and safe to train the immune system to accept a transplanted ...
A collaborative research team from Jilin University, Tongji Hospital of Huazhong University of Science and Technology, and the Institute of Zoology, Chinese Academy of Sciences, has demonstrated that ...
A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...
Animal-to-human organ transplants promise a future where survival no longer depends on another person’s death.
A close friend of mine recently received an organ transplant, and another acquaintance is considering becoming a living donor ...
Dr. David Kalfa, a professor and researcher at FIU Medicine and chief of cardiovascular surgery and co-director of the ...
UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results